RETROSPECTIVE COMPARISON OF PHENYTOIN AND LEVETIRACETAM AS SEIZURE PROPHYLAXIS WITH HIGH DOSE BUSULFAN DURING ALLOGENEIC STEM CELL TRANSPLANT

被引：0
作者：
Mathew, S. [1 ]
Harnicar, S. [1 ]
Adel, N. [1 ]
Papadopoulos, E. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.595
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
557
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
[41]   High dose acyclovir for cytomegalovirus infection prophylaxis after allogeneic stem cell transplantation [J].
Iannella, E. ;
Lori, A. P. ;
Torelli, G. F. ;
Milano, F. ;
Capobianchi, A. ;
Lucarelli, B. ;
Malandruccolo, L. ;
Valle, V. ;
Arleo, E. ;
Martino, P. ;
Foa, R. ;
Gentile, G. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 :103-103
[42]   Busulfan dose adjustment in children for hematopoietic stem cell transplant. [J].
Lee, V ;
Li, CK ;
Wong, R ;
Shing, MKM ;
Chik, KW ;
Yuen, MPP .
BLOOD, 2001, 98 (11) :348B-348B
[43]   ORAL LORAZEPAM PREVENTS SEIZURE DURING HIGH-DOSE BUSULFAN IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A Prospective Study [J].
Hamidieh, Amir Ali ;
Hamedani, Ravak ;
Hadjibabaie, Molouk ;
Amini, Mohsen ;
Sadrai, Sima ;
Ghavamzadeh, Ardeshir .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (07) :529-533
[44]   Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan [J].
D Caselli ;
O Ziino ;
A Bartoli ;
G Santangelo ;
F Vanadia ;
M Aricò .
Bone Marrow Transplantation, 2008, 42 :135-136
[45]   Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan [J].
Caselli, D. ;
Ziino, O. ;
Bartoli, A. ;
Santangelo, G. ;
Vanadia, F. ;
Arico, M. .
BONE MARROW TRANSPLANTATION, 2008, 42 (02) :135-136
[46]   Relationship Between Intravenous Busulfan Pharmacokinetics and Patient Characteristics in Allogeneic Stem Cell Transplant [J].
Keisler, Meredith D. ;
Simmons, Ashley E. ;
Ivanova, Anastasia ;
Walko, Christine M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :S292-S292
[47]   Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter? [J].
Jain, Tania ;
Kunze, Katie L. ;
Khetarpal, Banveet K. ;
McCallen, Margaret R. ;
Betcher, Jeffrey A. ;
Ofori, Henry T. ;
Khera, Nandita ;
Slack, James L. ;
Leis, Jose F. ;
Sproat, Lisa Z. ;
Noel, Pierre ;
Palmer, Jeanne .
LEUKEMIA & LYMPHOMA, 2019, 60 (08) :2034-2041
[48]   Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities [J].
Popat, Uday R. ;
Pasvolsky, Oren ;
Bassett, Roland, Jr. ;
Mehta, Rohtesh S. ;
Olson, Amanda ;
Chen, Julianne ;
Alousi, Amin M. ;
Al-Atrash, Gheath ;
Bashir, Qaiser ;
Gulbis, Alison M. ;
Hosing, Chitra M. ;
Im, Jin S. ;
Kebriaei, Partow ;
Khouri, Issa ;
Marin, David ;
Nieto, Yago ;
Oran, Betul ;
Saini, Neeraj ;
Shigle, Terri Lynn ;
Srour, Samer A. ;
Ramdial, Jeremy L. ;
Rezvani, Katayoun ;
Qazilbash, Muzaffar H. ;
Andersson, Borje S. ;
Champlin, Richard E. ;
Shpall, Elizabeth J. .
BLOOD ADVANCES, 2023, 7 (20) :6196-6205
[49]   Fluconazole 200 mg Daily As Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Retrospective Review [J].
Maher, Keri Renee ;
McBride, Ali ;
Chen, Christopher Chun Man ;
Lim, Melissa ;
Majeed, Aneela ;
Hunt, Taylor ;
Farooqui, Sarmad Riaz ;
Riddle, Zach ;
Yeager, Andrew M. ;
Anwer, Faiz .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) :S181-S181
[50]   Low dose ambisome anti-fungal prophylaxis in pediatric allogeneic unrelated hematopoietic stem cell transplant [J].
Shinkle, M. ;
Carver, A. ;
Quinones, R. ;
Foreman, N. ;
Gore, L. ;
Peltz, A. ;
Christensen, M. ;
Wightman, C. ;
Kissane, R. ;
Malcolm, J. ;
Hild, E. ;
Giller, R. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) :80-80
12345